{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:24:14Z","timestamp":1769106254191,"version":"3.49.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"32","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1016\/j.vaccine.2010.05.057","type":"journal-article","created":{"date-parts":[[2010,6,10]],"date-time":"2010-06-10T09:01:27Z","timestamp":1276160487000},"page":"5272-5279","source":"Crossref","is-referenced-by-count":58,"title":["Immunogenicity and safety of the human rotavirus vaccine Rotarix\u2122 co-administered with routine infant vaccines following the vaccination schedules in Europe"],"prefix":"10.1016","volume":"28","author":[{"given":"Timo","family":"Vesikari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aino","family":"Karvonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Prymula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Schuster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan C.","family":"Tejedor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Thollot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garcia-Corbeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Damaso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Htay-Htay","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alain","family":"Bouckenooghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2010.05.057_bib1","doi-asserted-by":"crossref","first-page":"304","DOI":"10.3201\/eid1202.050006","article-title":"Rotavirus and severe childhood diarrhea","volume":"12","author":"Parashar","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.057_bib2","doi-asserted-by":"crossref","unstructured":"The Pediatric ROTavirus European CommitTee (PROTECT). The pediatric burden of rotavirus disease in Europe. Epidemiol Infect 2006; 134:908\u201316.","DOI":"10.1017\/S0950268806006091"},{"key":"10.1016\/j.vaccine.2010.05.057_bib3","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/01.inf.0000197622.98559.01","article-title":"Burden of rotavirus disease in European Union countries","volume":"25","author":"Soriano-Gabarr\u00f3","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.05.057_bib4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.vaccine.2003.11.037","article-title":"Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999\u20132000","volume":"22","author":"Gil","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1651-2227.1999.tb14322.x","article-title":"Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features","volume":"426","author":"Vesikari","year":"1999","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.vaccine.2010.05.057_bib6","doi-asserted-by":"crossref","first-page":"3962","DOI":"10.1016\/j.vaccine.2007.02.072","article-title":"Evaluating rotavirus vaccination in England and Wales Part I. Estimating the burden of disease","volume":"25","author":"Harris","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib7","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1016\/j.vaccine.2007.02.070","article-title":"Evaluating rotavirus vaccination in England and Wales Part II. The potential cost-effectiveness of vaccination","volume":"25","author":"Jit","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib8","doi-asserted-by":"crossref","first-page":"6121","DOI":"10.1016\/j.vaccine.2009.08.030","article-title":"The cost-effectiveness of rotavirus vaccination: comparative analyses for five European countries and transferability in Europe","volume":"27","author":"Jit","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib9","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0264-410X(97)00210-7","article-title":"Safety and immunogenicity of a live attenuated human rotavirus 89-12 vaccine","volume":"16","author":"Bernstein","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib10","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(98)12106-2","article-title":"Efficacy of live attenuated human rotavirus vaccine 89-12 in infants","volume":"354","author":"Bernstein","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.05.057_bib11","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1086\/344732","article-title":"Second year follow-up evaluation of live attenuated human rotavirus vaccine 89-12 in healthy infants","volume":"186","author":"Bernstein","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.057_bib12","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1016\/j.vaccine.2004.01.044","article-title":"Safety and immunogenicity of RIX4414 live attenuated human rotavirus vaccine in adults, toddlers and previously uninfected infants","volume":"22","author":"Vesikari","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2010.05.057_bib13","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1097\/01.inf.0000141722.10130.50","article-title":"Efficacy of RIX4414 live attenuated human rotavirus vaccine in Finnish infants","volume":"23","author":"Vesikari","year":"2004","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.05.057_bib14","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/431511","article-title":"Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants","volume":"192","author":"Phua","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.057_bib15","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/01.inf.0000164763.55558.71","article-title":"Comparative evaluation of safety and immunogenicity of two doses of an oral live attenuated human rotavirus vaccine","volume":"24","author":"Dennehy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.05.057_bib16","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.inf.0000178294.13954.a1","article-title":"Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine RIX4414: a randomized, placebo-controlled trial in Latin American infants","volume":"24","author":"Salinas","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.05.057_bib17","doi-asserted-by":"crossref","first-page":"e1062","DOI":"10.1542\/peds.2008-1059","article-title":"Co-administration of RIX4414 oral human rotavirus vaccine does not impact the immune response of antigens contained in routine infant vaccines in the United States","volume":"122","author":"Dennehy","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2010.05.057_bib18","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomized, double-blind controlled study","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2010.05.057_bib19","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.05.057_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/infdis\/159.1.79","article-title":"Effect of antibodies to rotavirus on protection of adults challenged with human rotavirus","volume":"159","author":"Ward","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.057_bib21","unstructured":"World Health Organization (WHO\/V&B\/02,19), Vaccines and Biologicals. Acute intussusception in infants and children. Incidence, clinical presentation and management: a global perspective; 2002 www.who.int\/vaccines-documents\/."},{"key":"10.1016\/j.vaccine.2010.05.057_bib22","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2010.05.057_bib23","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00006454-200202000-00003","article-title":"Lack of association between rotavirus infection and intussusception: implications for use of attenuated rotavirus vaccines","volume":"21","author":"Chang","year":"2002","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.vaccine.2010.05.057_bib24","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1086\/431512","article-title":"More on RotaShield and intussusception: the role of age at the time of vaccination","volume":"192","author":"Simonsen","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2010.05.057_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X10007668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T12:53:09Z","timestamp":1544446389000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X10007668"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":25,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2010,7]]}},"alternative-id":["S0264410X10007668"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2010.05.057","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}